Validity of triage systems for paediatric emergency care: a systematic review

Maria Clara de Magalhães-Barbosa1, Jaqueline Rodrigues Robaina1, Arnaldo Prata-Barbosa1,2

  • 1Department of Paediatrics, Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, RJ, Brazil.

Insights

This review found evidence supporting the validity of the Manchester Triage System (MTS), Canadian Triage and Acuity Scale (PedCTAS), and Emergency Severity Index (ESI v.4) for pediatric emergency care. Continued efforts are needed to improve sensitivity and reduce undertriage rates.

Area of Science:

  • Emergency Medicine
  • Pediatric Care
  • Health Systems Research

Background:

  • Paediatric emergency care relies on accurate triage systems to prioritise patient needs.
  • The validity of various paediatric triage systems requires systematic evaluation.

Purpose of the Study:

  • To systematically review the validity of established triage systems for paediatric emergency care.
  • To identify which systems demonstrate the most robust evidence for accuracy.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (MEDLINE, LILACS, etc.) with no time restrictions.
  • Included studies focused on five-level triage systems for patients aged 0-18 years.
  • Data extraction and quality assessment followed PRISMA guidelines.

Main Results:

  • Twenty-five studies evaluated seven triage systems, including the Manchester Triage System (MTS), paediatric Canadian Triage and Acuity Scale (PedCTAS), and Emergency Severity Index version 4 (ESI v.4).
  • MTS, PedCTAS, and ESI v.4 had the most moderate and high-quality studies, showing consistent association with hospitalisation and resource use.
  • Undertriage was identified across systems, with low-urgency patients being hospitalised.

Conclusions:

  • The MTS, PedCTAS, and ESI v.4 show evidence of validity in their respective regions.
  • Further research should focus on enhancing sensitivity and minimizing undertriage.
  • Cross-cultural adaptation is crucial for successful implementation in new settings.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
371
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302
Tertiary Healthcare System01:21

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care...
2.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
354